Journal of Inherited Metabolic Disease

Preface
pp. 303-304(2)

After the genome—the phenome?
pp. 305-317(13)
Author: Scriver C.R.

Retrotransposon-derived elements in the mammalian genome: A potential source of disease
pp. 319-330(12)
Authors: Druker R.; Whitelaw E.

The genetics and pathophysiology of diabetes mellitus type II
pp. 331-347(17)
Authors: Jenkins A.B.; Campbell L.V.

Mitochondrial disorders: Prevalence, myths and advances
pp. 349-362(14)
Author: Thorburn D.R.

Protein substitutes for PKU: What's new?
pp. 363-371(9)
Authors: Macdonald A.; Daly A.; Davies P.; Asplin D.; Hall S.K.; Rylance G.; Chakrapani A.

Hepatocyte transplantation for inborn errors of metabolism
pp. 373-383(11)
Author: Burlina A.B.

Enzyme replacement and enhancement therapies for lysosomal diseases
pp. 385-410(26)
Author: Desnick R.J.

Treatment of lysosomal storage disorders: Cell therapy and gene therapy
pp. 411-415(5)
Authors: Eto Y.; Shen J.-S.; Meng X.-L.; Ohashi T.

Glycine encephalopathy (nonketotic hyperglycinaemia): Review and update
pp. 417-422(6)
Authors: Applegarth D.A.; Toone J.R.

Congenital disorders of glycosylation (CDG): Update and new developments
pp. 423-426(4)
Author: Jaeken J.